Key result
Referral decisions based on a pre-hospital HEART score were non-inferior to routine hospital transfer for 45-day MACE (15.7% vs 16.6%; HR 0.88; 95% CI 0.63-1.25).
Why the study?
Whether paramedic referral decisions based on pre-hospital risk stratification in suspected NSTE-ACS are safe and do not increase MACE in daily practice had not been investigated.
Does pre-hospital triage using the HEART score to avoid hospitalization in low-risk patients increase MACE in patients with suspected NSTE-ACS?
Cohort (n=1,236)
Does pre-hospital triage using the HEART score to avoid hospitalization in low-risk patients increase MACE in patients with suspected NSTE-ACS?
Hazard Ratio: 0.88 (95% CI 0.63–1.25)
Absolute Event Rate: 15.7% vs 16.6%
p-value: p=0.67
Pre-hospital risk stratification using the HEART score to avoid hospitalization in low-risk patients with suspected NSTE-ACS is feasible and non-inferior to routine hospital referral.
No significant MACE reduction observed; leaves open whether Phase III risk refinements improve stratification in acute coronary care.
AIMS: Although pre-hospital risk stratification of patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) by ambulance paramedics is feasible, it has not been investigated in daily practice whether referral decisions based on this risk stratification is safe and does not increase major adverse cardiac events (MACE). In Phase III of the FamouS Triage study, it was investigated whether referral decisions by ambulance paramedics based on a pre-hospital HEART score, is non-inferior to routine management. METHODS AND RESULTS: FamouS Triage Phase III is a non-inferiority study, comparing the occurrence of MACE before (Phase II) and after (Phase III) implementation of referral decisions based on a pre-hospital HEART score. In Phase II, all patients were risk-stratified and referred to the hospital; in Phase III, low-risk patients (HEART score ≤ 3) were not referred. Primary endpoint was MACE (acute coronary syndrome, revascularization, or death) within 45 days. A total of 1236 patients were included. Mean age was 63 years, 43% were female, 700 patients were included in the second phase and 536 in the third phase in which 149 low-risk patients (28%) were not transferred to the hospital. Occurrence of 45 days MACE was 16.6% in Phase II and 15.7% in Phase III (P = 0.67). Percentage MACE in low-risk patients was 2.9% in Phase II and 1.3% in Phase III. After adjustments for differences in baseline variables, the hazard ratio of 45 days MACE in Phase III was 0.88 (95% confidence interval 0.63-1.25) as compared to Phase II. CONCLUSION: Pre-hospital risk stratification of patients with suspected NSTE-ACS, avoiding hospitalization of a substantial number of low-risk patients, seems feasible and non-inferior to transferring all patients to the hospital.
No takes yet. Share an insight, caveat, or question.
Tolsma et al. (2021) conducted a cohort in suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) (n=1,236). Referral decisions based on a pre-hospital HEART score vs. Routine management (referring all patients to the hospital) was evaluated on MACE (acute coronary syndrome, revascularization, or death) within 45 days (HR 0.88, 95% CI 0.63-1.25, p=0.67). Referral decisions based on a pre-hospital HEART score were non-inferior to routine hospital transfer for 45-day MACE (15.7% vs 16.6%; HR 0.88; 95% CI 0.63-1.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: